Though there was a similar trend at week 1 and pre-dose #2, this did not reach statistical significance (median week 1: 53.0 μg/mL, IQR 49.5–67.5 μg/mL for age <10 years vs. 60.4 μg/mL IQR 51.0–81.8 μg/m L for age ≥10 years, p = 0.5; pre-dose #2: 30.7 μg/mL, IQR 23.6–44.6 μg/mL for age <10 years vs. 42.9 μg/mL, IQR 26.5–52.1 μg/mL for age ≥10 years, p = 0.6).
1
0.5000
0.5000